Last week was a rough one for Canopy Growth Corp (TSX:WEED)(NYSE:CGC). The stock had already been struggling in recent months and after the company released its first-quarter results, the stock fell even further, falling below $40 a share for the first time since January. At over $37 to finish the week, Canopy Growth is right around its 52-week low and there’s the…
Read More
Cannabis investors have had a rough ride in the last 12 months. Several stocks lost significant value due to regulatory issues and missing analyst target estimates. Cannabis stocks were overvalued and expensive. Shares of Cronos Group (TSX:CRON)(NASDAQ:CRON) have fallen 46% since March 2019. Despite the recent pullback, the stock has returned a mind-blowing 1,825% since its IPO back in December…
Read More
Last week was not a good one for Canopy Growth Corporation (TSX:WEED)(NYSE:CGC). After some of its competitors announced solid earnings — including a few who told investors they were profitable — Canopy Growth disappointed the market when it announced adjusted EBITDA of negative $92 million. That came on net revenue of just over $90 million, which was lower than analysts…
Read More
It’s been a wild ride for cannabis investors so far this summer, and not like in the summer of 2018. Whereas last year, there were the super highs from investors excited about the new industry, after several ups and downs, investors have become a lot more wary of where stocks are headed. With some cannabis stocks reporting profits and others…
Read More
While cannabis stocks have not performed well since early April, the month of July was especially brutal for the sector. There is no doubt that the drama surrounding CannTrust Holdings (TSX:TRST)(NYSE:CRST) had a lot to do with this catastrophic performance. However, there may be a silver lining — or at least an important lesson to glean — from this scandal,…
Read More
It seems there is no respite for CannTrust (TSX:TRST)(NYSE:CTST) investors. CannTrust stock was down 4.1% yesterday after the company announced that products worth $2.9 million were returned by the Ontario Cannabis Store (OCS). The OCS, which is in charge of Canada’s wholesale to retail distribution, deemed the products to be “non-conforming.” This is the latest drawback for CannTrust and its…
Read More
CannTrust Holdings (TSX:TRST)(NYSE:CTST) is the latest marijuana stock to be hit by a major scandal. Investors who are following the story are wondering if they should take a contrarian position in the shares or avoid the stock altogether. Background CannTrust is the target of a Health Canada investigation that came about as the apparent result of a tip from a…
Read More
Marijuana stocks took a huge hit this past Wednesday, as the Horizons Medical Marijuana Life Sciences ETF (which tracks the sector) fell 5.87% in a single day. The day was a bad one for the TSX and for stocks worldwide, but weed stocks were hit worse than most: the TSX fell just 1.86% on the same date. Between the CannTrust Holdings Inc (TSX:TRST)(NYSE:CTST)…
Read More
As the one-year anniversary of cannabis legalization in Canada approaches, a new strain of marijuana production will soon be available to Canadians: edibles. As of October 17, 2019, amended regulations to the Cannabis Act will take effect, though Canadians likely won’t see any edibles available both in-store or online until mid-December at the earliest. As an investor, you might be…
Read More
Momentum investing is a ridiculously simple strategy that many investors swear leads to better returns. All the scheme does is load up on the best short-term performing stocks and rides them until they start to fizzle out. New companies are found at that point, and the whole process repeats itself. See? I told you it was easy. It’s also been…
Read More